← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Executive Chair Philip Astley-Sparke sold $245K of Replimune Group, Inc.

Sold$245,394
$6.47Price
37,928Shares
−2%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Thu, May 16. Filed Mon, May 20, 8:04 PM ET, after the close. Not investment advice.